 | DelMar Pharmaceuticals, Inc. (DMPI) CEO Saiid Zarrabian on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - May 23 at 7:42 PM |
| DelMar Pharma up 32% as rights offering progresses
seekingalpha.com - May 21 at 5:40 PM |
 | DelMar Pharmaceuticals Announces Expansion of Scientific Advisory Board
finance.yahoo.com - May 20 at 10:58 PM |
| DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2019 Financial Results
finance.yahoo.com - May 15 at 8:03 AM |
| DelMar Pharma files updated prospectus for subscription rights offering
seekingalpha.com - May 8 at 7:55 PM |
| DelMar Pharmaceuticals Announces 1-for-10 Reverse Stock Split
finance.yahoo.com - May 7 at 7:19 PM |
 | Head to Head Review: DelMar Pharmaceuticals (DMPI) vs. Emisphere Technologies (EMIS)
www.americanbankingnews.com - May 5 at 2:43 PM |
| DelMar Pharma files for subscription rights offering; shares down 2% premarket
seekingalpha.com - April 18 at 10:01 AM |
| DelMar Pharmaceuticals Receives Approval from MD Anderson Cancer Center's IRB for Protocol Expansion to Include Maintenance Stage MGMT-unmethylated GBM Patients in Ongoing Phase 2 Trial of VAL-083
finance.yahoo.com - April 3 at 8:59 AM |
 | DelMar Pharmaceuticals Inc.
www.barrons.com - March 4 at 5:52 PM |
| DelMar Pharmaceuticals, Inc. (DMPI) CEO Saiid Zarrabian on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - February 20 at 10:09 AM |
| DelMar Pharmaceuticals Achieves Halfway Enrollment Point for Phase 2 Clinical Trial of VAL-083 in Newly Diagnosed MGMT-unmethylated GBM
finance.yahoo.com - February 20 at 10:09 AM |
 | Form 8-K DelMar Pharmaceuticals, For: Feb 12 - StreetInsider.com
www.streetinsider.com - February 13 at 9:59 AM |
| DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2019 Financial Results
finance.yahoo.com - February 12 at 9:34 AM |
| DelMar Pharmaceuticals Receives Nasdaq Listing Extension
finance.yahoo.com - February 7 at 9:23 AM |
| Form SC 13G DelMar Pharmaceuticals, Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
www.streetinsider.com - November 27 at 8:00 AM |
| Form 8-K DelMar Pharmaceuticals, For: Nov 25 - StreetInsider.com
www.streetinsider.com - November 27 at 8:00 AM |
 | Consolidated Research: 2018 Summary Expectations for iKang Healthcare Group, Collectors Universe, QuickLogic ...
globenewswire.com - November 25 at 8:00 AM |
| Consolidated Research: 2018 Summary Expectations for iKang Healthcare Group, Collectors Universe, QuickLogic, The Ultimate Software Group, Internet Gold Golden Lines, and DelMar Pharmaceuticals — Fundamental Analysis, Key Performance Indications
finance.yahoo.com - November 23 at 8:03 AM |
 | DelMar Presents Clinical Update on VAL-083 From Ongoing First- and Second-Line Trials in Patients with MGMT ...
www.prnewswire.com - November 21 at 5:24 PM |
| DelMar Pharmaceuticals, Inc. (DMPI) CEO Saiid Zarrabian on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - November 21 at 8:00 AM |
| DelMar Presents Clinical Update on VAL-083 From Ongoing First- and Second-Line Trials in Patients with MGMT-unmethylated GBM at The Society for NeuroOncology Annual Meeting
finance.yahoo.com - November 20 at 8:08 AM |
| DelMar Pharmaceuticals net loss improves in Q1
seekingalpha.com - November 14 at 8:01 AM |
| DelMar Pharmaceuticals Announces First Quarter Fiscal Year 2019 Financial Results
finance.yahoo.com - November 14 at 8:01 AM |
| Who Owns Most Of DelMar Pharmaceuticals Inc (NASDAQ:DMPI)?
finance.yahoo.com - October 16 at 5:10 PM |
| DelMar Announces Further Validation of the Mechanism of Action of VAL-083
finance.yahoo.com - October 10 at 8:01 AM |
| DelMar Pharmaceuticals, Inc. (DMPI) CEO Saiid Zarrabian on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - September 26 at 8:01 AM |
| DelMar Pharmaceuticals reports Q4 results
seekingalpha.com - September 24 at 5:10 PM |
| DelMar Pharmaceuticals Announces Fiscal Year 2018 Annual Financial Results
finance.yahoo.com - September 24 at 9:08 AM |
| DelMar Pharmaceuticals Appoints Oppenheimer & Co. Inc. as Strategic Advisor
www.prnewswire.com - September 4 at 8:03 AM |
| DelMar Pharmaceuticals appoints Oppenheimer & Co as strategic advisor
seekingalpha.com - September 4 at 8:03 AM |
| DelMar Pharmaceuticals Announces Accelerated Patient Enrollment of Phase 2 Trial in MGMT-unmethylated Recurrent GBM
finance.yahoo.com - June 26 at 8:53 AM |
| DelMar Pharmaceuticals Appoints World-Renowned Molecular Biologist Dr. Napoleone Ferrara to Board of Directors
finance.yahoo.com - June 25 at 10:30 AM |
| DelMar Pharmaceuticals, Inc. (DMPI) CEO Saiid Zarrabian on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - May 31 at 8:00 AM |
 | BRIEF-Delmar Appoints Saiid Zarrabian Full-Time President And CEO
www.reuters.com - May 23 at 5:33 PM |
| Delmar Pharma (DMPI) Names Saiid Zarrabian as Full-Time President and CEO
www.streetinsider.com - May 23 at 5:33 PM |
| DelMar Appoints Saiid Zarrabian to Full-Time President and CEO
finance.yahoo.com - May 22 at 8:00 AM |
| DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2018 Financial Results
www.prnewswire.com - May 17 at 5:49 AM |
| Delmar Pharma (DMPI) Presents Positive Updates on Two Ongoing Clinical Trials with VAL-083 for Treatment of MGMT-unmethylated GBM
www.streetinsider.com - April 27 at 5:28 PM |
| DelMar Pharmaceuticals Presents Positive Updates on Two Ongoing Clinical Trials with VAL-083 for Treatment of MGMT-unmethylated GBM
finance.yahoo.com - April 17 at 5:39 PM |
| DelMar Pharmaceuticals Announces Multiple Presentations at Annual Meeting of the American Association for Cancer Research
finance.yahoo.com - April 16 at 9:09 AM |
| BRIEF-Delmar Pharmaceuticals To Increase Number Of Authorized Shares Of Stock, Par Value Of $0.001, Per Share ...
www.reuters.com - April 15 at 5:43 PM |
| Today’s Research Reports on Stocks to Watch: Lipocine and DelMar Pharmaceuticals
finance.yahoo.com - February 28 at 8:44 AM |
| DelMar Pharmaceuticals' (DMPI) Management on Q2 2018 Results ... - Seeking Alpha
seekingalpha.com - February 22 at 8:11 AM |
| DelMar Pharmaceuticals Announces Second Quarter Fiscal Year ... - PR Newswire (press release)
www.prnewswire.com - February 15 at 7:24 AM |
| DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2018 Financial Results
finance.yahoo.com - February 15 at 7:24 AM |
| Is DelMar Pharmaceuticals Inc (NASDAQ:DMPI) A Healthcare Industry Laggard Or Leader?
finance.yahoo.com - February 14 at 3:32 PM |
 | DelMar Pharmaceuticals' stock rockets after cancer treatment granted 'Fast Track' designation - MarketWatch
www.marketwatch.com - December 28 at 8:18 AM |
 | A Peek Into The Markets: US Stock Futures Down; Mallinckrodt To Acquire Sucampo Pharmaceuticals - Benzinga
www.benzinga.com - December 26 at 9:06 AM |
| Delmar Pharma (DMPI) Gramted Fast Track Designation for VAL ... - StreetInsider.com
www.streetinsider.com - December 26 at 9:06 AM |
